{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:35:49Z","timestamp":1787884549635,"version":"build-2784847793"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.7759\/cureus.96770","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:16:57Z","timestamp":1763050617000},"source":"Crossref","is-referenced-by-count":1,"title":["Device-Related Adverse Events and Modes of Failure in Renal Denervation Systems: Insights From the Food and Drug Administration Manufacturer and User Facility Device Experience (FDA MAUDE) Database Analysis"],"prefix":"10.7759","author":[{"given":"Manasa","family":"Jasti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravinda","family":"Nanjundappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timir","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.10265","article-title":"Renal denervation: a treatment for hypertension and chronic kidney disease","volume":"72","author":"Singh RR","year":"2018","unstructured":"Singh RR, Denton KM. Renal denervation: a treatment for hypertension and chronic kidney disease. Hypertension. 2018, 72:528-36. 10.1161\/HYPERTENSIONAHA.118.10265","journal-title":"Hypertension"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000240","article-title":"Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association","volume":"81","author":"Cluett JL","year":"2024","unstructured":"Cluett JL, Blazek O, Brown AL, et al.. Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association. Hypertension. 2024, 81:e135-48. 10.1161\/HYP.0000000000000240","journal-title":"Hypertension"},{"key":"ref3","unstructured":"Manufacturer and User Facility Device Experience (MAUDE) database. (2024). Accessed. April 11, 2024: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/TextSearch.cfm."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2021.0175","article-title":"Current status and future perspectives of renal denervation","volume":"51","author":"Choi KH","year":"2021","unstructured":"Choi KH, Choi SH. Current status and future perspectives of renal denervation. Korean Circ J. 2021, 51:717-32. 10.4070\/kcj.2021.0175","journal-title":"Korean Circ J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-19-00902","article-title":"Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation","volume":"16","author":"Townsend RR","year":"2020","unstructured":"Townsend RR, Walton A, Hettrick DA, et al.. Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation. EuroIntervention. 2020, 16:89-96. 10.4244\/EIJ-D-19-00902","journal-title":"EuroIntervention"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt DL","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O'Neill WW, et al.. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014, 370:1393-401. 10.1056\/NEJMoa1402670","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011499.pub3","article-title":"Renal denervation for resistant hypertension","volume":"11","author":"Pisano A","year":"2021","unstructured":"Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D. Renal denervation for resistant hypertension. Cochrane Database Syst Rev. 2021, 11:CD011499. 10.1002\/14651858.CD011499.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/360507-device-related-adverse-events-and-modes-of-failure-in-renal-denervation-systems-insights-from-the-food-and-drug-administration-manufacturer-and-user-facility-device-experience-fda-maude-database-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:16:59Z","timestamp":1763050619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/360507-device-related-adverse-events-and-modes-of-failure-in-renal-denervation-systems-insights-from-the-food-and-drug-administration-manufacturer-and-user-facility-device-experience-fda-maude-database-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.96770","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}